Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.

Nowak J, Malzahn U, Baur AD, Reichelt U, Franiel T, Hamm B, Durmus T.

Acta Radiol. 2016 Jan;57(1):107-14. doi: 10.1177/0284185114561915. Epub 2014 Dec 12.

PMID:
25505225
2.

MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.

Durmuş T, Reichelt U, Huppertz A, Hamm B, Beyersdorff D, Franiel T.

Diagn Interv Radiol. 2013 Sep-Oct;19(5):411-7. doi: 10.5152/dir.2013.13055.

3.

Optimized culture conditions for tissue explants of uterine leiomyoma.

Fiebitz A, Fritsch M, Reichelt U, Ruester C, Chiantera V, Vercellino GF, Darwish A, Schneider A, Mechsner S.

Clin Lab. 2012;58(11-12):1153-64.

PMID:
23289184
4.

Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.

Drenckhan A, Kurschat N, Dohrmann T, Raabe N, Koenig AM, Reichelt U, Kaifi JT, Izbicki JR, Gros SJ.

J Surg Res. 2013 Jun 15;182(2):250-6. doi: 10.1016/j.jss.2012.09.035. Epub 2012 Oct 10.

PMID:
23117118
5.

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Gros SJ, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Effenberger K, Reichelt U, Hoffman RM, Pantel K, Kaifi JT, Izbicki JR.

PLoS One. 2012;7(10):e47287. doi: 10.1371/journal.pone.0047287. Epub 2012 Oct 17. Erratum in: PLoS One. 2013;8(5). doi: 10.1371/annotation/5dafa9a8-2e6d-4487-b35f-7126141fe00e.

6.

Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).

Baumunk D, Reichelt U, Hildebrandt J, Krause H, Ebbing J, Cash H, Miller K, Schostak M, Weikert S.

World J Urol. 2013 Oct;31(5):1191-6. doi: 10.1007/s00345-012-0874-5. Epub 2012 Apr 29.

PMID:
22544372
7.

High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis.

Reichelt U, Keichel S, Barcena de Arellano ML, Chiantera V, Schneider A, Mechsner S.

Reprod Sci. 2012 Aug;19(8):876-82. doi: 10.1177/1933719112438440. Epub 2012 Apr 26.

PMID:
22539358
8.

[Leiomyoma. A rare neoplasia of the parotid gland].

Lehmann S, Tzamalis G, Reichelt U, Jovanovic S.

HNO. 2012 Jul;60(7):659-61. doi: 10.1007/s00106-012-2505-2. German.

PMID:
22532283
9.

VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.

Schultze A, Ben Batalla I, Riethdorf S, Bubenheim M, Yekebas E, Erbersdobler A, Reichelt U, Effenberger KE, Schmidt T, Izbicki JR, Bokemeyer C, Pantel K, Fiedler W, Loges S.

Clin Exp Metastasis. 2012 Dec;29(8):879-87. doi: 10.1007/s10585-012-9477-1. Epub 2012 Apr 8.

PMID:
22484977
10.

GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy.

Jentzmik F, Krause H, Reichelt U, Schrader AJ, Schrader M, Baumunk D, Cash H, Miller K, Schostak M.

World J Urol. 2012 Aug;30(4):541-6. doi: 10.1007/s00345-011-0764-2. Epub 2011 Sep 24.

PMID:
21947551
11.

Immunohistochemical characterization of endometriosis-associated smooth muscle cells in human peritoneal endometriotic lesions.

Barcena de Arellano ML, Gericke J, Reichelt U, Okuducu AF, Ebert AD, Chiantera V, Schneider A, Mechsner S.

Hum Reprod. 2011 Oct;26(10):2721-30. doi: 10.1093/humrep/der253. Epub 2011 Aug 10.

PMID:
21831994
12.

Lymphangiogenesis in deep infiltrating endometriosis.

Keichel S, Barcena de Arellano ML, Reichelt U, Riedlinger WF, Schneider A, Köhler C, Mechsner S.

Hum Reprod. 2011 Oct;26(10):2713-20. doi: 10.1093/humrep/der230. Epub 2011 Jul 25.

PMID:
21791438
13.

[Introduction of interdisciplinary prostate cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years after accreditation].

Weikert S, Baumunk D, Stephan C, Cash H, Jahnke K, Steiner U, Werthemann P, Kempkensteffen C, Magheli A, Hinz S, Jagota A, Reichelt U, Busch J, Klopf C, Miller K, Schostak M.

Urologe A. 2011 Sep;50(9):1083-8. doi: 10.1007/s00120-011-2629-0. German.

PMID:
21728009
14.

L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.

Rawnaq T, Quaas A, Zander H, Gros SJ, Reichelt U, Blessmann M, Wilzcak W, Schachner M, Sauter G, Izbicki JR, Kaifi JT.

J Surg Res. 2012 Apr;173(2):314-9. doi: 10.1016/j.jss.2010.10.029. Epub 2010 Nov 21.

PMID:
21195422
15.

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.

Fusi A, Reichelt U, Busse A, Ochsenreither S, Rietz A, Maisel M, Keilholz U.

J Invest Dermatol. 2011 Feb;131(2):487-94. doi: 10.1038/jid.2010.285. Epub 2010 Sep 30.

16.

Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Tachezy M, Reichelt U, Melenberg T, Gebauer F, Izbicki JR, Kaifi JT.

Histol Histopathol. 2010 Oct;25(10):1239-46. doi: 10.14670/HH-25.1239.

PMID:
20712008
17.

Clostridium difficile infection of the small bowel--two case reports with a literature survey.

Holmer C, Zurbuchen U, Siegmund B, Reichelt U, Buhr HJ, Ritz JP.

Int J Colorectal Dis. 2011 Feb;26(2):245-51. doi: 10.1007/s00384-010-1001-y. Epub 2010 Jul 14.

PMID:
20628882
18.

Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma.

Gros SJ, Kurschat N, Dohrmann T, Reichelt U, Dancau AM, Peldschus K, Adam G, Hoffman RM, Izbicki JR, Kaifi JT.

Mol Cancer Ther. 2010 Jul;9(7):2037-45. doi: 10.1158/1535-7163.MCT-10-0209. Epub 2010 Jul 6.

19.

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.

Kalinina T, Bockhorn M, Kaifi JT, Thieltges S, Güngör C, Effenberger KE, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki JR, Yekebas EF.

Int J Cancer. 2010 Oct 15;127(8):1931-40. doi: 10.1002/ijc.25196.

20.

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.

Gnjatic S, Cao Y, Reichelt U, Yekebas EF, Nölker C, Marx AH, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling KL, Cerundolo V, Luetkens T, Ritter G, Friedrichs K, Leuwer R, Hegewisch-Becker S, Izbicki JR, Bokemeyer C, Old LJ, Atanackovic D.

Int J Cancer. 2010 Jul 15;127(2):381-93. doi: 10.1002/ijc.25058.

21.

[BeO-OSL detectors for dose measurements in cell cultures].

Andreeff M, Sommer D, Freudenberg R, Reichelt U, Henniger J, Kotzerke J.

Nuklearmedizin. 2009;48(6):227-32. doi: 10.3413/nukmed-0261. Epub 2009 Oct 26. German.

PMID:
19862463
22.

Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.

Gros SJ, Dohrmann T, Peldschus K, Schurr PG, Kaifi JT, Kalinina T, Reichelt U, Mann O, Strate TG, Adam G, Hoffman RM, Izbicki JR.

Int J Cancer. 2010 Jun 1;126(11):2671-81. doi: 10.1002/ijc.24980.

23.

Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.

Schurr P, Kohrs D, Reichelt U, Kaifi J, Vashist Y, Bachmann K, Bogoevski D, Yekebas E, Izbicki J.

Dig Surg. 2009;26(3):229-35. doi: 10.1159/000219932. Epub 2009 May 26.

PMID:
19468233
24.

Signet ring cell adenocarcinoma of the oropharynx: presentation of a rare case and review of the literature.

Veit JA, Reichelt U, Tesche S.

Auris Nasus Larynx. 2009 Dec;36(6):717-20. doi: 10.1016/j.anl.2009.01.013. Epub 2009 May 15. Review.

PMID:
19446973
25.

Clear-cell odontogenic carcinoma: a new case and long-term follow-up of an old case, and review of the literature.

Werle H, Blake FA, Reichelt U, Schmelzle R, Heiland M.

J Oral Maxillofac Surg. 2009 Jun;67(6):1342-8. doi: 10.1016/j.joms.2008.06.020. Review. No abstract available.

PMID:
19446231
26.

Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.

Rawnaq T, Kleinhans H, Uto M, Schurr PG, Reichelt U, Cataldegirmen G, Gawad KA, Yekebas EF, Schachner M, Izbicki JR, Kaifi JT.

Anticancer Res. 2009 Apr;29(4):1195-9.

27.

Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.

Marx A, Wandrey T, Simon P, Wewer A, Grob T, Reichelt U, Minner S, Simon R, Spehlmann M, Tigges W, Soehendra N, Seitz U, Seewald S, Izbicki JR, Yekebas E, Kaifi JT, Mirlacher M, Terracciano L, Fleischmann A, Raedler A, Sauter G.

Hum Pathol. 2009 Feb;40(2):166-73. doi: 10.1016/j.humpath.2008.06.027. Epub 2008 Oct 5.

PMID:
18835622
28.

Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.

Schurr PG, Oikonomou D, Kaifi JT, Merkert P, Wolter S, Kleinhans H, Reichelt U, Mann O, Gawad KA, Strate T, Yekebas EF, Izbicki JR.

J Clin Gastroenterol. 2009 Jan;43(1):27-35. doi: 10.1097/MCG.0b013e3181581914.

PMID:
18469721
29.

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

Stoecklein NH, Hosch SB, Bezler M, Stern F, Hartmann CH, Vay C, Siegmund A, Scheunemann P, Schurr P, Knoefel WT, Verde PE, Reichelt U, Erbersdobler A, Grau R, Ullrich A, Izbicki JR, Klein CA.

Cancer Cell. 2008 May;13(5):441-53. doi: 10.1016/j.ccr.2008.04.005.

30.

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer.

Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, Strate T, Schneider C, Pantel K, Schachner M, Sauter G, Izbicki JR.

Mod Pathol. 2007 Nov;20(11):1183-90. Epub 2007 Sep 14.

31.

Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic masses.

Wachowiak R, Kaifi J, Schwarzenbach H, Yekebas E, Merkert P, Schurr P, Hansen B, Reichelt U, Strate T, Pantel K, Izbicki JR.

Diagn Mol Pathol. 2007 Sep;16(3):174-8.

PMID:
17721326
32.

Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.

Link BC, Reichelt U, Schreiber M, Kaifi JT, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad KA, Issa R, Koops S, Izbicki JR, Yekebas EF.

Ann Surg Oncol. 2007 Sep;14(9):2591-9. Epub 2007 Jun 5.

PMID:
17549567
33.

Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors.

Oikonomou D, Hassan K, Kaifi JT, Fiegel HC, Schurr PG, Reichelt U, Aridome K, Yekebas EF, Mann O, Kluth D, Strate T, Izbicki JR.

J Cancer Res Clin Oncol. 2007 Dec;133(12):951-5. Epub 2007 May 30.

PMID:
17534660
34.

[Swelling of the neck region].

Kutta H, Reichelt U, Wenzel S.

HNO. 2007 Jul;55(7):557-9. German. No abstract available.

PMID:
17415539
35.

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.

Schurr PG, Strate T, Rese K, Kaifi JT, Reichelt U, Petri S, Kleinhans H, Yekebas EF, Izbicki JR.

Ann Surg. 2007 Feb;245(2):273-81.

36.

Midkine as a prognostic marker for gastrointestinal stromal tumors.

Kaifi JT, Fiegel HC, Rafnsdottir SL, Aridome K, Schurr PG, Reichelt U, Wachowiak R, Kleinhans H, Yekebas EF, Mann O, Ichihara-Tanaka K, Muramatsu T, Kluth D, Strate T, Izbicki JR.

J Cancer Res Clin Oncol. 2007 Jul;133(7):431-5. Epub 2007 Jan 13.

PMID:
17221186
37.

Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.

Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W.

Clin Cancer Res. 2007 Jan 1;13(1):76-80.

38.

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.

Reichelt U, Duesedau P, Tsourlakis MCh, Quaas A, Link BC, Schurr PG, Kaifi JT, Gros SJ, Yekebas EF, Marx A, Simon R, Izbicki JR, Sauter G.

Mod Pathol. 2007 Jan;20(1):120-9. Epub 2006 Nov 24.

39.

Allelic loss of Hox11L1 gene locus predicts outcome of gastrointestinal stromal tumors.

Kaifi JT, Wagner M, Schurr PG, Wachowiak R, Reichelt U, Yekebas EF, Mann O, Vashist Y, Kleinhans H, Link BC, Strate T, Kalinin V, Izbicki JR.

Oncol Rep. 2006 Oct;16(4):915-9.

PMID:
16969514
40.

Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.

Schurr P, Wolter S, Kaifi J, Reichelt U, Kleinhans H, Wachowiak R, Yekebas E, Strate T, Kalinin V, Simon R, Sauter G, Schaefer H, Izbicki J.

Clin Cancer Res. 2006 Sep 1;12(17):5151-7.

41.

Application of advanced Monte Carlo Methods in numerical dosimetry.

Reichelt U, Henniger J, Lange C.

Radiat Prot Dosimetry. 2006;119(1-4):479-82. Epub 2006 May 18.

PMID:
16709706
42.

Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas.

Kaifi JT, Heidtmann S, Schurr PG, Reichelt U, Mann O, Yekebas EF, Wachowiak R, Strate T, Schachner M, Izbicki JR.

Anticancer Res. 2006 Mar-Apr;26(2A):1167-70.

43.

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

Kaifi JT, Zinnkann U, Yekebas EF, Schurr PG, Reichelt U, Wachowiak R, Fiegel HC, Petri S, Schachner M, Izbicki JR.

World J Gastroenterol. 2006 Jan 7;12(1):94-8.

44.

L1 (CD171) is highly expressed in gastrointestinal stromal tumors.

Kaifi JT, Strelow A, Schurr PG, Reichelt U, Yekebas EF, Wachowiak R, Quaas A, Strate T, Schaefer H, Sauter G, Schachner M, Izbicki JR.

Mod Pathol. 2006 Mar;19(3):399-406.

45.

Juvenile polyposis coli: a facultative precancerosis with some similarities to ulcerative colitis?

Reichelt U, Hopfer H, Roch N, Izbicki JR, Erbersdobler A.

Pathol Res Pract. 2005;201(7):517-20.

PMID:
16164047
47.

Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis.

Tsokos M, Reichelt U, Nierhaus A, Püschel K.

Int J Legal Med. 2001;114(4-5):237-43.

PMID:
11355402
48.

Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period.

Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K.

Forensic Sci Int. 2001 Jun 1;119(1):47-56.

PMID:
11348793

Supplemental Content

Loading ...
Support Center